These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 6231391)

  • 61. Cytolytic activity of natural killer cells and lymphokine activated killer cells against hepatitis A virus infected fibroblasts.
    Baba M; Hasegawa H; Nakayabu M; Fukai K; Suzuki S
    J Clin Lab Immunol; 1993; 40(2):47-60. PubMed ID: 7932628
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Analysis of human lymphocyte subpopulations responsible for antibody-dependent and spontaneous cell-mediated cytotoxicity.
    Perussia B; Trinchieri G; Cerottini JC
    Transplant Proc; 1979 Mar; 11(1):793-5. PubMed ID: 313102
    [No Abstract]   [Full Text] [Related]  

  • 63. T cell chronic lymphocytic leukaemia with suppressor phenotype.
    Hofman FM; Smith D; Hocking W
    Clin Exp Immunol; 1982 Aug; 49(2):401-9. PubMed ID: 6215199
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Immunoregulatory functions of neoplastic lymphoid cells and their humoral products.
    Okawa H; Inada M; Suzuki M; Yata J
    Cancer; 1985 Jul; 56(2):309-17. PubMed ID: 3159471
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Impaired antigen presentation in toxic epidermal necrolysis.
    Bagot M; Charue D; Heslan M; Wechsler J; Roujeau JC; Revuz J
    Arch Dermatol; 1993 Jun; 129(6):721-7. PubMed ID: 8507074
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The evaluation of prognostic value of immunological markers in acute lymphoblastic leukemia (ALL) after intensification of treatment schedule.
    Bogusławska-Jaworska J; Rodziewicz B
    Arch Immunol Ther Exp (Warsz); 1986; 34(4):392-5. PubMed ID: 3492185
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [The lymphocyte abnormality in CNS disease].
    Matsubara H; Igata A
    No To Shinkei; 1983 May; 35(5):423-31. PubMed ID: 6354216
    [No Abstract]   [Full Text] [Related]  

  • 68. Studies on the immune status of children with acute lymphocytic leukaemia. I. Early phase before and after first remission.
    Hitzig WH; Plüss HJ; Joller P; Pilgrim U; Tacier-Eugster H; Jakob M
    Clin Exp Immunol; 1976 Dec; 26(3):403-13. PubMed ID: 1087593
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Immunological characteristics of lymphocytes during intensive treatment maintaining remission of acute lymphoblastic leukemia in children and following withdrawal from chemotherapy].
    Kaftański R
    Acta Haematol Pol; 1979; 10(2):99-106. PubMed ID: 289275
    [TBL] [Abstract][Full Text] [Related]  

  • 70. K cell activity in acute lymphoblastic leukaemia of childhood.
    Schilirò G; Musumeci S; Sciotto A; Russo A; Marino S
    Acta Haematol; 1980; 64(4):221-3. PubMed ID: 6781202
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Data obtained by the study of membrane markers of human lymphoid cells in disease].
    Seligmann M; Preud'homme JL; Brouet JC
    Schweiz Med Wochenschr; 1977 Dec; 107(49):1798-807. PubMed ID: 337473
    [No Abstract]   [Full Text] [Related]  

  • 72. Study of B and T lymphocyte surface markers in breast cancer patients using anti-B and anti-T cell monoclonal antibodies.
    Nowak JS; Lanzrein C
    Neoplasma; 1984; 31(3):281-9. PubMed ID: 6610835
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Alloantigen-induced suppressor- and memory cells in chronic lymphocytic leukemia.
    Kabelitz D; Fink U; Reichert A; Rastetter J
    Immunobiology; 1982 May; 161(5):457-63. PubMed ID: 6212533
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Immunological and molecular classification of acute lymphoblastic leukemia.
    Foa R; Migone N; Gavosto F
    Haematologica; 1986; 71(4):277-85. PubMed ID: 3096821
    [No Abstract]   [Full Text] [Related]  

  • 75. Decreased natural killer cell activity in children with untreated acute leukemia.
    Nasrallah AG; Miale TD
    Cancer Res; 1983 Nov; 43(11):5580-5. PubMed ID: 6352019
    [TBL] [Abstract][Full Text] [Related]  

  • 76. T-lymphocytes in B-cell chronic lymphocytic leukaemia.
    Lauria F; Foà R
    Haematologica; 1985; 70(5):445-50. PubMed ID: 2419209
    [No Abstract]   [Full Text] [Related]  

  • 77. Coincident change of cellular function and phenotype in the course of a suppressor T cell acute lymphocytic leukaemia.
    Sieber G; Ludwig WD; Teichmann H; Herrmann F; Rühl H
    Clin Exp Immunol; 1985 Jun; 60(3):483-8. PubMed ID: 3160512
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Immunoregulatory T cell abnormalities in mucocutaneous lymph node syndrome.
    Leung DY; Chu ET; Wood N; Grady S; Meade R; Geha RS
    J Immunol; 1983 May; 130(5):2002-4. PubMed ID: 6220072
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Current concepts in immunology: Regulation of the immune response--inducer and suppressor T-lymphocyte subsets in human beings.
    Reinherz EL; Schlossman SF
    N Engl J Med; 1980 Aug; 303(7):370-3. PubMed ID: 6446683
    [No Abstract]   [Full Text] [Related]  

  • 80. The study of T-, B-, O- lymphocytes in acute lymphoblastic leukemia.
    Bogusławska-Jaworska J; Chybicka A
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):859-66. PubMed ID: 312091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.